Jennifer N. Choi, MD, FAAD
SESSIONS
F024 A Primer and Practical Approach to Cancer Checkpoint Inhibitors for the Dermatologist
Mar 28, 2026
•
9:00 AM - 11:00 AM
•
Bluebird 1B
F043 New Drugs, New Rashes: An Update on Cutaneous Drug Eruptions
Mar 28, 2026
•
3:30 PM - 5:30 PM
•
Room 301
U081 Toxic Erythema of Chemotherapy: Comprehensive Approach to Diagnosis and Management
Mar 29, 2026
•
4:30 PM - 5:30 PM
•
Bluebird 1C
DISCLOSURES
CeraVe/Valeante – Independent Contractor(Fees); Janssen Global Services, LLC – Advisory Board(Fees); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Fees); OnQuality Pharmaceuticals, Ltd. – Advisory Board(Fees); PraHealth Sciences – Advisory Board(Fees); Pyxis Oncology – Advisory Board(Fees); Regeneron Pharmaceuticals, Inc. – Data Safety Monitoring Board(Fees);